Immunotherapy of lymphomas with T cells modified by anti-CD20 scFv/CD28/CD3zeta recombinant gene. | Leuk Lymphoma;49(7): 1368-73, 2008 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Immunotherapy of lymphomas with T cells modified by anti-CD20 scFv/CD28/CD3zeta recombinant gene.

Yu, Kang; Hu, Yongxian; Tan, Yinxia; Shen, Zhijian; Jiang, Songfu; Qian, Honglan; Liang, Bin; Shan, Daming.

Affiliation

Yu K; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, Zhejiang, China.

Leuk Lymphoma ; 49(7): 1368-73, 2008 Jul.

Article in En | MEDLINE | ID: mdl-18452062

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / T-Lymphocytes / Immunotherapy, Adoptive / Lymphoma Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / T-Lymphocytes / Immunotherapy, Adoptive / Lymphoma Limits: Humans Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Country of publication: